Revisiting the relationship between tumour volume and diameter in advanced NSCLC patients: An exercise to maximize the utility of each measure to assess response to therapy.

[1]  I. Steffen,et al.  Size determination and response assessment of liver metastases with computed tomography--comparison of RECIST and volumetric algorithms. , 2013, European journal of radiology.

[2]  P. Jänne,et al.  Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non–Small-Cell Lung Cancer Patients Treated with EGFR TKI , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  P. Jänne,et al.  RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0. , 2013, AJR. American journal of roentgenology.

[4]  H. Hatabu,et al.  Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST. , 2012, AJR. American journal of roentgenology.

[5]  Andrew J Buckler,et al.  Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer. , 2012, Translational oncology.

[6]  Chuong D. Hoang,et al.  Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  B. Alexander,et al.  Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy. , 2011, International journal of radiation oncology, biology, physics.

[8]  L. Schwartz,et al.  Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Hiroto Hatabu,et al.  New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. , 2010, AJR. American journal of roentgenology.

[10]  William Pao,et al.  A Pilot Study of Volume Measurement as a Method of Tumor Response Evaluation to Aid Biomarker Development , 2010, Clinical Cancer Research.

[11]  Binsheng Zhao,et al.  Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. , 2009, Radiology.

[12]  P. Lambin,et al.  Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[13]  M. Meyerson,et al.  Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Schwartz,et al.  Lung cancer: computerized quantification of tumor response--initial results. , 2006, Radiology.

[15]  P S Albert,et al.  Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors. , 2001, Journal of the National Cancer Institute.

[16]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[17]  A. D. Van den Abbeele,et al.  CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool. , 2011, Academic radiology.

[18]  Tracy T Batchelor,et al.  Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. , 2006, Neuro-oncology.

[19]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.